FR1604537A - Vaccine for cattle - Google Patents

Vaccine for cattle

Info

Publication number
FR1604537A
FR1604537A FR1604537DA FR1604537A FR 1604537 A FR1604537 A FR 1604537A FR 1604537D A FR1604537D A FR 1604537DA FR 1604537 A FR1604537 A FR 1604537A
Authority
FR
France
Prior art keywords
mixtures
agent
added
inactivating
myxovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1604537A publication Critical patent/FR1604537A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18611Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Process for preparing vaccines against shipping fever in cattle by inactivating virus- and bacteria cultures with an inactivating agent. To cultures of Myxovirus parainfluenza-3 or mixtures of this with Pasteurella multocida and/or Past. haemolytica, an aluminium ion-containing agent is added having an Al-content equivalent to 10-50 ml of a 1.3% Al2O3 dispersion in water/ 100 ml culture. The agent is added before- or after combination of the 3 organisms to form one or more mixtures. The mixtures must have an optical density of 5-10 times the optical density of tube 1 on the McFarland scale, whereby the Myxovirus parainfluenza-3 and Pasteurella organisms are inactivated before or after forming the final mixture by treatment with an inactivating agent, followed by neutralisation of any excess. A parenterally acceptable antiseptic in bacteriostatic- and fungistatic amounts is then added.
FR1604537D 1967-09-15 1967-09-15 Vaccine for cattle Expired FR1604537A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR121186 1967-09-15

Publications (1)

Publication Number Publication Date
FR1604537A true FR1604537A (en) 1971-11-29

Family

ID=8638423

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1604537D Expired FR1604537A (en) 1967-09-15 1967-09-15 Vaccine for cattle

Country Status (1)

Country Link
FR (1) FR1604537A (en)

Similar Documents

Publication Publication Date Title
CH407071A (en) Process for the production of ethyl alcohol
AT260520B (en) Process for the production of an ethylene copolymer
AT303385B (en) Process for the preparation of aqueous dispersions
AT274349B (en) Process for the preparation of aqueous solutions containing high molecular weight polyacrylamide and sodium polyacrylate
FR1604537A (en) Vaccine for cattle
FR1604109A (en) Live attenuated rabies vaccine is produced by culturing the virus in chick embryo tissue contng. 0.5-5% of a hydrolysed collagen deriv., such as gelatin, which
CH480434A (en) Process for the preparation of the antibiotic kasugamycin
AT255659B (en) Process for the preparation of sterile, non-toxic aerosol solutions
CH489470A (en) Process for the production of L-ornithine by fermentation
CH521334A (en) Process for the preparation of curable cycloaliphatic glycidyl ethers
CH466894A (en) Process for the preparation of a vaccine against infectious gastroenteritis
AT247287B (en) Process for the preparation of a salt mixture rich in potassium peroxomonosulfate
DE2135246B2 (en) METHOD FOR PRODUCING L-TYROSINE BY MICROBIOLOGICAL WAYS
AT273952B (en) Process for the preparation of 1- (2'-hydroxyethyl) -2-carbamoyl-5-nitropyrrole
GB1201052A (en) Vaccines
CH460503A (en) Process for the production of a bacterial preparation
CH535281A (en) Process for preparing a non-anaphylactic PPAO vaccine
AT259527B (en) Process for the preparation of dispersions
AT279038B (en) Process for the preparation of a vaccine against rubella
CH515991A (en) Process for the preparation of the antibiotic tsushimycin
CH415674A (en) Process for the preparation of derivatives of 3-phenyl-7-oxychromone
GB949400A (en) Poliomyelitis vaccines
AT314832B (en) Process for the preparation of a hydroxy ether
AT232282B (en) Process for the production of high molecular weight polyoxymethylenes
FR1180507A (en) Advanced process for sterilizing water with ozonated air